ImClone Systems to Host Webcast of May 24, 2001 Annual Meeting
Monday May 21, 6:31 am Eastern Time
Press Release
NEW YORK--(BW HealthWire)--May 21, 2001--ImClone Systems Incorporated (Nasdaq: IMCL - news) announced today that its annual meeting will be
webcast live on Thursday, May 24, 2001 at 10:00 A.M. E.T. The webcast will be available live and via replay through Sunday, June 3, 2001 at
www.imclone.com, in the ``Investor Relations'' section of the website.
The management of ImClone Systems Incorporated will review the Company's progress and deliver an overview of its anticipated 2001 milestones. The
presentation will take place at 10:00 A.M. E.T. on Thursday, May 24, 2001, from the Azekka Room of Le Parker Meridien Hotel in New York City.
ImClone Systems Incorporated is committed to advancing oncology care by developing a portfolio of targeted biologic treatments, designed to address the medical
needs of patients with a variety of cancers. The Company's three programs include growth factor blockers, cancer vaccines and angiogenesis inhibitors. ImClone
Systems' strategy is to become a fully integrated biopharmaceutical company, taking its development programs from the research stage to the market. ImClone
Systems is headquartered in New York with manufacturing facilities in Somerville, New Jersey. |
